CIK 0001108205 · Non-accelerated filer<br>Smaller reporting company
CURIS INC
Sign in to watch- Ticker
- CRIS
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 043505116
- Phone
- 617-503-6500
- Business address
- 128 SPRING STREET, BUILDING C, SUITE 500, LEXINGTON, MA, 02421
- 4 Open-market sale Head of Research & Development sold 5,500 shares at $1.07 ($5,900)
- 4 Open-market sale Director sold 18,500 shares at $1.05 ($19,475)
- 4 Open-market sale Director sold 18,500 shares at $1.05 ($19,477)
- 4 Open-market sale Director sold 14,800 shares at $1.05 ($15,581)
- 4 Open-market sale Director sold 14,800 shares at $1.05 ($15,587)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- SC 13G/A Stake Amended Statement of Ownership
- 8-K Event Delisting notice
- SC 13G Stake Amended Statement of Ownership
- S-8 Other Securities Offered to Employees in Benefit Plans
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Derivatives Options or other derivatives
- 8-K Event Executive or director change
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- SC 13G/A Stake Amended Statement of Ownership
Page 18 of 61 · 1,213 filings